Health and Human Services News and Research

RSS

China, WHO to collaborate on flu research center

Chinese and WHO officials last week agreed to open a flu research center in Beijing, Bloomberg reports. "The new collaborating center for reference and research on influenza will join a network of WHO-affiliated labs in Atlanta, London, Tokyo and Melbourne that monitor flu strains and make recommendations on vaccines to fight the virus," the news service writes

17 Nov 2009

Startling new mammogram guidelines incite debate about risk, cost

The Washington Post: "Women in their 40s should stop routinely having annual mammograms and older women should cut back to one scheduled exam every other year, an influential federal task force has concluded, challenging the use of one of the most common medical tests" (Stein, 11/17).

17 Nov 2009

DNA banking: A step toward preserving history and improving the health of future generations

This Thanksgiving Day marks the sixth annual National Family History Day, a U.S. Department of Health and Human Services initiative to encourage families to discuss their health history. Holiday gatherings are excellent opportunities for discussing and documenting family disease backgrounds which can save the lives of loved ones through early detection and preventive measures.

17 Nov 2009

Healthy adults may have better immunity to 2009 H1N1 influenza virus, says study

A new study shows that molecular similarities exist between the 2009 H1N1 influenza virus and other strains of seasonal H1N1 virus that have been circulating in the population since 1988. These results suggest that healthy adults may have a level of protective immune memory that can blunt the severity of infection caused by the 2009 H1N1 influenza virus.

17 Nov 2009

FDA approves CSL's seasonal and H1N1 flu vaccines for children

The U.S. Food and Drug Administration has approved the use of the CSL Limited's seasonal and 2009 H1N1 influenza vaccines to include children ages 6 months and older. These vaccine were previously approved for use in adults, ages 18 years and older

17 Nov 2009

NIH awards $3 million grant to ASU professors for research on rapid DNA sequencing technology

Arizona State University has been awarded nearly $3 million in federal stimulus funds from the National Institutes of Health. ASU professors Stuart Lindsay and Paul Westerhoff will lead a pair of two-year, innovative projects designed to tackle challenges in the fields of rapid DNA sequencing and the potential health risks of nanotechnology.

17 Nov 2009

Additional vaccine for 2009 H1N1 flu approved by FDA

The U.S. Food and Drug Administration announced that it has approved a fifth vaccine for protection against the 2009 H1N1 influenza virus. The vaccine is manufactured by ID Biomedical Corp. of Quebec, Canada, owned by GlaxoSmithKline PLC.

16 Nov 2009

Sequella broadens the licensed therapeutic indications of its SQ109 lead drug candidate

Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing products to treat life-threatening infectious diseases, today announced that it amended an existing agreement with the National Institutes of Health (NIH) to significantly broaden the licensed therapeutic indications, or "field of use," for Sequella's lead drug candidate, SQ109.

16 Nov 2009

Electronic health records not yet making impact, patients turn to web for advice

As the United States launches "an ambitious program, backed by $19 billion in government incentives, to accelerate the adoption of computerized patient records in doctors' offices and hospitals," a new study of 3,000 hospitals "has found little difference in the cost and quality of care," The New York Times reports.

16 Nov 2009

FDA issues a Complete Response Letter for Human Genome Sciences' raxibacumab BLA

Human Genome Sciences, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) relating to the Company’s Biologics License Application (BLA) requesting the approval of raxibacumab for use in the treatment of inhalational anthrax. The FDA issues Complete Response Letters to request additional information needed to complete the review of a BLA.

16 Nov 2009

UT physicians treat Iraqi girl with myasthenia gravis

Plagued by a growing weakness that left her unable to walk, talk and even take a normal breath, 11-year-old Iraqi Aram Ali was a shell of the bright little girl she used to be.

16 Nov 2009

Feds overlooked Medicare scam warnings, The AP reports

The Associated Press reports that the Centers For Medicare and Medicaid Services "received roughly 30 warnings from inspectors (on suspected Medicare fraud) over three years during the Bush and Obama administrations but didn't respond to half of them, even after repeated letters." The news story was based on records received from Sen. Chuck Grassley's office.

16 Nov 2009

CMS report on House health bill: Many more insured means more, not less, spending

The Associated Press: "Overall spending on health care would rise as a result of legislation approved a week ago by the House, and billions of dollars in projected savings contained in the measure will be difficult to maintain, according to a report by a top official at the agency that oversees Medicare.

16 Nov 2009

CCH issues a special Briefing on employer and Medicaid-related provisions

CCH has issued a special Briefing on the employer and Medicare- and Medicaid-related provisions in the House version of health care reform, detailing provisions of the legislation approved on November 7.

16 Nov 2009

National Data Collection Center for primary research phase of the Index launched

The Advisory Council for the U.S. Healthcare Efficiency Index(TM) (Index), founded by Emdeon, today announced the launch of the National Data Collection Center for the primary research phase of the Index and the addition of new members.

13 Nov 2009

CSL's H1N1 influenza vaccine receives approval from FDA for use in children ages 6 months and older

The U.S. Food and Drug Administration has approved the use of the CSL Limited's 2009 H1N1 influenza vaccine to include children ages 6 months and older. This vaccine was previously approved only for use in adults, ages 18 years and older.

13 Nov 2009

RERF awarded $9.7M to study the effects of atomic bomb radiation and aging on the human immune system

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded nearly $9.7 million over five years to the Radiation Effects Research Foundation (RERF), Japan, to study the effects of atomic bomb radiation and aging on the human immune system.

13 Nov 2009

Kaiser NW to pay $1.83M for settling False Claims Act liability

Kaiser Foundation Hospitals - Kaiser Sunnyside Medical Center, Kaiser Foundation Health Plan of the Northwest and Northwest Permanente P.C., Physicians & Surgeons (collectively, Kaiser NW) has agreed to pay the United States $1,830,322.41 to settle False Claims Act liability, the Justice Department announced today.

13 Nov 2009

FDA approves CSL Biotherapies' seasonal flu vaccine, Afluria for children

CSL Biotherapies, a subsidiary of CSL Limited, one of the world’s leading manufacturers of influenza vaccine, announced that the U.S. Food and Drug Administration (FDA) has approved the company’s application for accelerated approval of its seasonal flu vaccine, Afluria® (Influenza Virus Vaccine) for use in the pediatric population aged 6 months and older.

12 Nov 2009

Results from an analysis emphasizes the financial burden of SMI on the criminal justice and HHS systems

Results from a large, retrospective analysis of inmates with a serious mental illness (SMI) underscores the financial burden of mental illness on the criminal justice and health and human services (HHS) systems, and may provide useful information to policy makers.

12 Nov 2009

Health and Human Services News and Research

China, WHO to collaborate on flu research center

Startling new mammogram guidelines incite debate about risk, cost

DNA banking: A step toward preserving history and improving the health of future generations

Healthy adults may have better immunity to 2009 H1N1 influenza virus, says study

FDA approves CSL's seasonal and H1N1 flu vaccines for children

NIH awards $3 million grant to ASU professors for research on rapid DNA sequencing technology

Additional vaccine for 2009 H1N1 flu approved by FDA

Sequella broadens the licensed therapeutic indications of its SQ109 lead drug candidate

Electronic health records not yet making impact, patients turn to web for advice

FDA issues a Complete Response Letter for Human Genome Sciences' raxibacumab BLA

UT physicians treat Iraqi girl with myasthenia gravis

Feds overlooked Medicare scam warnings, The AP reports

CMS report on House health bill: Many more insured means more, not less, spending

CCH issues a special Briefing on employer and Medicaid-related provisions

National Data Collection Center for primary research phase of the Index launched

CSL's H1N1 influenza vaccine receives approval from FDA for use in children ages 6 months and older

RERF awarded $9.7M to study the effects of atomic bomb radiation and aging on the human immune system

Kaiser NW to pay $1.83M for settling False Claims Act liability

FDA approves CSL Biotherapies' seasonal flu vaccine, Afluria for children

Results from an analysis emphasizes the financial burden of SMI on the criminal justice and HHS systems

Event guide: 6th Operationalize Expanded Access Programs Summit East eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News